Ruminant Feed Ban Support Project (93.449)

Program

93.449 Ruminant Feed Ban Support Project

Federal Agency

Agency: Department of Health and Human Services
Office: Food and Drug Administration

Authorization

Public Health Security and Bioterrorism Preparedness and Response Act of 2002, Public Law 107-188.

Program Number

93.449

Last Known Status

Active

Objectives

To assist in an increased surveillance presence throughout the commercial feed channels to prevent the introduction or amplification of Bovine Spongiform Encephalopathy (BSE) in the United States.

Types of Assistance

Cooperative Agreements

Uses and Use Restrictions

Funds are to be used for location and visitation of firms involved in the manufacture, distribution and transportation of animal feed, and operations feeding ruminant animals in their jurisdiction, to verify compliance with the ruminant feed ban. Visitations could include annual inspections of renderers, protein blenders and feed mills that manufacture animal feeds and feed ingredients utilizing materials prohibited under the ruminant feed ban that are not covered under existing FDA contracts and other agreements. Funds can be used for inspections of salvagers of food and feed, and transporters of animal feed and feed ingredients, supplies, training, laboratory equipment for feed sample testing, and as a supplement to the annual State program appropriations. Funds may not be used to replace annual State program funds for these purposes. Specific funding restrictions are as noted in the Funding Opportunity Announcement (FOA) and the Notice of Grant Award.

Eligibility Requirements

Applicant Eligibility

This cooperative agreement program is only available to State and Tribal Feed/BSE regulatory programs.

Beneficiary Eligibility

The general public, State and Tribal Feed/BSE regulatory programs.

Credentials/Documentation

Applications must present a plan and furnish evidence that facilities, personnel and equipment are appropriate to carry out the project specific objectives as stated in the Funding Opportunity Announcement as published in the Federal Register or NIH Guide. These awards are subject to Executive Order 12372 as it applies. OMB Circular No. A-87 applies to this program.

Application and Award Process

Preapplication Coordination

Preapplication coordination is required. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.

Application Procedure

This program is excluded from coverage under OMB Circular No. A-102. This program is excluded from coverage under OMB Circular No. A-110. The standard application forms noted in the Funding Opportunity Announcement (FOA) and published in the NIH Guide or Federal Register and as provided by the FDA through Grants.gov, and as required by 45 CFR 72 must be used for this program. All applications for new, competing continuations or competing supplemental research grants must complete the required forms through Grants.gov The application packages are posted under the "APPLY" section of this announcement under http://www.grants.gov.

Award Procedure

All accepted applications receive a scientific review for technical merit and a recommnedation for approval by an appropriate initial Ad Hoc Review group. All approved and scored applications compete for available funds on the basis of score, scientific merit and programmatic relevance. Geographic distribution will be a consideration in the award selection process.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time

From 90 to 120 days.

Appeals

From 30 to 60 days.

Renewals

From 90 to 120 days. Renewals are available. Procedures are the same as for new applications.

Assistance Considerations

Formula and Matching Requirements

Statutory formulas are not applicable to this program.

Matching requirements are not applicable to this program.

MOE requirements are not applicable to this program.

Length and Time Phasing of Assistance

The length of support will depend on the nature of the projects, program relevance and the availability of funds. For those projects with an expected duration of more than 1 year, future recommended support for up to 5 years will depend on 1) performance during the preceeding year and 2) availability of Federal funds. See the following for information on how assistance is awarded/released: Notice of Award will be provided via electronic or hard copy.

Post Assistance Requirements

Reports

Program Reports are required as noted in the FOA and the Terms and Conditions of Award. Cash reports are not applicable. Progress Reports are required as stated in the FOA and the Terms and Conditions of Award. Expenditure Reports are required as stated in the FOA and the Terms and Conditions of Award. Performance Monitoring is required as stated in the FOA and the Terms and Conditions of Award.

Audits

In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In accordance with the provisions of OMB Circular No. A-133 (e.g. most recent revision), "Audits of States, Local Governments and Nonprofit Organizations," nonfederal entities that expend financial assistance of $300,000 ($500,000 for fiscal years ending after December 31, 2003) or more in Federal awards will have a single or program-specific audit conducted for that year except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.

Records

All cooperative agreement documentation must be retained for 3 years from the day on which the grantee submits the final financial status report for the project period. Progress reports, expenditures and other financial records must be retained for 3 years from the day on which the grantee submits the final financial status report for the project period. Financial and programmatic records, supporting documents, statistical records and all other records that are required by the terms of the grant or may be considered pertinent to a grant must be retained for 3 years from the date the grantee submits the final financial status report for the report period. See 45 CFR 74.53 and 92.42 for exceptions and qualification to the 3 year retention requirement. See 45 CFR 74.48 and 92.36 for record retention and access requirements for contracts under grants.

Program Accomplishments

Not Applicable.

Financial Information

Account Identification

75-0600-0-1-554.

Obligations

(Cooperative Agreements) FY 08 $2,834,085; FY 09 est $2,848,721; FY 10 est $3,000,000

Range and Average of Financial Assistance

An average of $250,000 total cost per award/per year (direct and indirect cost combined) for up to five yeas as established in the FOA, recommended by Ad Hoc Review and indicated in the Terms and Conditions of Award.

Regulations, Guidelines and Literature

42 CFR Part 52-Grants for Research Projects; 45 CFR Part 74 - Uniform Administrative Requirements for Awards and Subawards to Institutions of Higher Education, Hospital, Other Nonprofit Organizations and Commercial Organizations; and certain grants and agreements with States, Local Governments and Indian Tribal Governments; 45 CFR Part 92-Uniform Administrative Requirements for Grants and Cooperative Agreements to State and Local Governments; the HHS Grants Policy Statement (most recent revision); Executive Order 12372, Intergovernmental Review of Federal Programs as implemented through 45 CFR Part 100--Intergovernmental Review of Department of Health and Human Services Programs and Activities.

Related Programs

93.103 Food and Drug Administration_Research; 93.448 Food Safety and Security Monitoring Project

Information Contacts

Regional or Local Office

See Regional Agency Offices.

Headquarters Office

Jennifer Gabb Division of Federal-State Relations, Office of Regulatory Affairs, HFC-150, 5600 Fishers Lane, Room 1207, Rockville, Maryland 20857 Email: jennifer.gabb@fda.hhs.gov Phone: 301-827-2899

Web Site Address

http://www.grants.gov/ or http://www.fda.gov/ora/fed_state/default.htm.

Examples of Funded Projects

Not Applicable.

Criteria for Selecting Proposals

All applications will be reviewed for responsiveness by the Grants Management Staff and the Office of Regulatory Affairs (ORA). To be responsive, the application must be submitted in accordance with the requirements of the FOA as published in the NIH Guide or the Federal Register. All responsive applications will be reviewed by an Ad Hoc Review committee. Each application will be scored and ranked based on the following criteria 1) availability of adequately trained staff; 2) detailed description of current feed regulatory program; 3) properly detailed budget that is intended to supplement State or Tribal appropriations; 4) accurate count of all feed facilities, etc., in the State or Tribal nation; 5) detailed description of how inspections are to be performed; 6) detailed descriptions of how current, non-inspected facilities will be identified and added to the State's inspection responsibilities: 7) ability to satisfy the reporting requirements; 8) provision of current funding level certification; 9) detailed methodology for program improvement; 10) justification for hiring new staff; and 11) detailed description of the enforcement of violative facilities; under the cooperative agreement all funding will be made by the Commissioner of the Food and Drug Administration or his designee.